Rationale: MicroRNAs modestly suppress their direct mRNA targets, and these direct effects are amplified by modulation of gene transcription pathways. Consequently, indirect mRNA modulatory effects of microRNAs to increase or decrease mRNAs greatly outnumber direct target suppressions. Because microRNAs are products of transcription, the potential exists for microRNAs that regulate transcription to regulate other microRNAs.
M
icroRNAs are important regulators of cardiac homeostasis and stress responses. By destabilizing messenger RNAs that encode proteins within cell metabolism, growth, calcium signaling, and programmed death pathways, microRNAs exert nodal control over critical biological processes. 1 Individual microRNA-mRNA interactions typically only fractionally reduce levels of the target mRNA, leading to the notion that microRNAs are fine tuners of cell functions. 2, 3 However, striking phenotypes can be induced when some microRNA levels are artificially manipulated and, especially, when all forms of a given microRNA are genetically ablated. 4, 5 The disparity between modest individual effects of a microRNA on its direct mRNA targets and the dramatic end-organ changes that can be provoked by microRNA gain-or loss-of-function 6 have been partially explained by targeting of transcriptional regulators by stress-regulated cardiac microRNAs. We designated the orchestration of nontarget mRNA levels through regulation of transcription pathways as epitranscriptional regulation. 7 Like all RNAs, microRNAs are products of transcription. It is, therefore, almost inescapable that microRNAs that regulate gene transcription also regulate the expression of some other microRNAs. An example of this type of microRNA-mediated microRNA regulation is the cross-regulation that occurs between members of the microRNA originating from myosin heavy chain gene (myomiR) family of microRNAs that are encoded within myosin heavy chain genes. 8, 9 Despite a strong logical foundation and the example of myomiRs, other microRNAs have been almost completely overlooked as microR-NA targets. Yet, microRNA-mediated microRNA regulation is being detected when properly assayed. 10 Thus, there is a critical need to determine whether cardiac microRNA-mediated microRNA regulation is unique to myomiRs. If such regulation is common, then these events illuminate a mechanism by which specific microRNAs can recruit to RNA-induced silencing complexes (RISCs) and suppress mRNAs that are not their direct targets, that is, indirect mRNA targeting.
Here, we investigated the potential for 3 structurally and functionally distinct cardiac-expressed microRNAs to direct microRNA-mediated cardiac microRNA regulation. We applied quantitative, unbiased, and genome-wide analytic techniques to novel mouse models in which microRNA (miR)-143, miR-378, and miR-499 were expressed at levels comparable with those described in diseased hearts. 11, 12 We observe that these microRNAs differ in their individual capacities to regulate expression of other cardiac-expressed microRNAs (cardiomiRs) in proportion to their modulation of gene transcription pathways. These results uncover a largely overlooked consequence of natural, artificial, or therapeutic microRNA regulation, microRNA-mediated microRNA regulation, that helps to explain unpredictable microRNA functions and that may contribute to off-target effects of synthetic molecules designed to inhibit microRNA function (antagomiR/antimiRs).
Methods

Mouse Models and Deep Sequencing Assays
Mice with Myh6-driven expression of pre-miR-143 and pre-miR-378 were created as previously described for miR-499. 11, 13 The late-developing cardiomyopathy phenotype of the miR-499 transgenic mice used herein has been reported (TG 15), 11 but its RNA expression signature was not characterized. Procedural and analytic techniques for deep mRNA and microRNA sequencing of mouse hearts have been previously described. 7, 14 Genome-wide significance for multiple mRNA and microRNA comparisons was established as ±25% regulation at a false discovery rate of 0.05.
MicroRNA Annotation Using miRBase 19
Previous nomenclature for microRNAs often described the minor product (passenger strand) of a microRNA stem-loop structure as a miR* form. In this article, we have annotated mouse microRNAs according to the nomenclature used by miRBase 19, released in August 2012 (http://www.mirbase.org/). 15, 16 microRNAs are designated as -5p or -3p forms according to their site of origin in the microRNA stem-loop precursor; the terms major or minor forms refer to abundance measured from our cardiac deep sequencing data.
Other detailed procedures and protocols are in the Online Data Supplement.
Results
Characteristics of miR-143, miR-378, and miR-499 in Mouse Hearts
We interrogated 3 abundant cardiomiRs previously reported to be increased in heart disease: miRs-143, -378(a), and -499. The regulatory and structural diversity ( Figure 1A ) of these microRNAs suggest different actions (reviewed by Condorelli et al 17 ) . The muscle-specific myomiR miR-499 is upregulated in human and experimental heart failure, 11, 12 and is implicated in transcriptional and post-translational regulation of pathological hypertrophy.
11 Ubiquitous miR-378 is upregulated in human heart failure and decreased or unchanged in murine cardiac hypertrophy, 7, 12, 18 and has been implicated in cardiac regulation of systemic metabolism. 19 miR-143 is upregulated in human heart failure, 12 but not in murine pressure-overload hypertrophy.
7 miR-143 is highly expressed in vascular smooth muscle 20 and in cardiomyocytes of the developing heart.
21-23
Because the relative expression levels of mature microRNAs for these 3 cardiomiRs have not been determined in adult heart myocyte and nonmyocyte cell populations, we isolated cardiomyocytes and nonmyocytes from hearts of normal adult mice. As shown in Figure 1B , all 3 microRNAs are measurable in cardiac myocyte RNA. miR-143 was slightly more abundant, and miR-499 was not detectable, in the nonmyocyte myocardial fraction. To quantify these 3 cardiomiRs in context, we performed deep sequencing of microRNAs from wild-type, 8-week mouse hearts. The 100 most abundant cardiomiRs are shown in Figure 1D (and data on a further 200 cardiomiRs are shown in Online Figure III) . Similarly to previous determinations using a separate cohort of mice, 7 miR-143 was 1 of the 2 most abundant cardiomiRs, miR-378 was the 4th most abundant, and miR-499 was the 47th most abundant cardiomiR.
Cardiac Overexpression of miR-143, miR-378, and miR-499
To overexpress miR-143 and -378, DNA fragments flanking the respective precursor microRNAs (pre-miR-143: 404 base pairs; pre-miR-378: 926 base pairs) were amplified from mouse genomic DNA and expressed using the Myh6 promoter ( Figure 2A ). This system drives cardiac miR expression shortly after birth, 24 which avoids potentially confounding developmental effects of embryonic microRNA expression. miR-499 was expressed using the same system. The cardiac phenotypes of different miR-499 cardiac transgenic mouse lines have been described, 11, 13 but current studies used a line (TG 15) in which the transcriptional and epitranscriptional characteristics were not previously determined. Each of the 3 transgenic microRNAs were expressed at levels ranging from 6 to 16 times their respective endogenous levels in nontransgenic lettermates ( Figure 2B ), which is within the range observed in cases of human heart failure. 11, 12 All transgenic mice were born at expected frequencies. miR-143 and miR-378 transgenic hearts were functionally normal by echocardiographic examination at 8 weeks of age, and were studied at that age (Online Figure I) . Because miR-499 induces cardiac hypertrophy and failure after 8 weeks, and hypertrophy/failure can primarily alter microRNA and mRNA expression, 7 we studied functionally normal hearts from 4-week-old miR-499 transgenic mice and age-matched littermate controls. Comparing the results of miR-499 mice at 4 weeks and miR-378 and miR-143 mice at 8 weeks was uncomplicated, because the levels of each microRNA used for transgenic overexpression are stable between those ages ( Figure 5A ).
Transcriptional Redirection by Cardiac-Expressed miR-143, miR-378, and miR-499
We interrogated the effects of miR-143, -378, and -499 on cardiac mRNA levels using deep RNA-sequencing. 14 A total of 1903 cardiac mRNAs were regulated by any expressed microRNA. Volcano plots depicting regulated mRNAs in each of the microRNA transgenic mouse lines are shown in Figure 3A . It is evident that miR-143 overexpression had little effect on cardiac mRNA levels at our prespecified levels of significance (25%-fold change; false discovery rate<0.05). By contrast, miR-378 and miR-499 each regulated large numbers of cardiac mRNAs (Online Table   Nonstandard Abbreviations and Acronyms cardiomiR cardiac-expressed microRNA myomiR microRNA originating from myosin heavy chain gene RISC RNA-induced silencing complex I). A heat map of cardiac mRNA levels in miR-143 mice ( Figure 3B ) confirms that the transcript profile is virtually indistinguishable from that of nontransgenic littermates, with only 17 mRNAs significantly regulated (1 of these is the previously determined miR-143 target, hexokinase 2 25-28 ; Online Table I ). By contrast, unsupervised hierarchical clustering of miR-378 and miR-499 transgenic mice and their respective nontransgenic controls reveals distinct mRNA signatures induced by miR-378 (954 regulated mRNAs) and miR-499 (1636 regulated mRNAs; Figure 3C and Online Table I ). Thus, these 3 microRNAs display varying abilities to regulate cardiac mRNA levels. The observation that ≈50% of all miR-378-regulated mRNAs and 40% of miR-499-regulated mRNAs were increased (rather than destabilized and decreased) reveals epitranscriptional effects of these 2 cardiac microRNAs (Online Table I ). 7, 11, 19 
MicroRNA Regulation of Cardiac microRNAs
To further assess gene expression control by miR-143, miR-378, and miR-499, we performed a systems analysis of the transcriptional signatures they invoke in mouse hearts. Principal components analysis of transcriptomes from each transgenic line validated the conclusion that miR-378 and miR-499 cardiac mRNA signatures are not only different from controls, but are remarkably distinct from each other ( Figure 4A ). By contrast, the miR-143 mRNA signature clustered together with the nontransgenic transcriptomes ( Figure 4A ). Thus, cardiomyocyte miR-143 overexpression does not meaningfully impact overall cardiac gene expression, whereas miR-378 and -499 do, but with different consequences.
MicroRNAs are encoded in the genome either as independent nonprotein-coding genes (≈56% of all mouse miRs) or within miRtrons, that is, microRNA-containing introns of protein-coding genes. 29 Regardless, microRNA expression is directed by cis elements that bind transcription factors. Therefore, microRNAs that directly or indirectly modulate transcriptional activity have the potential to regulate the expression of genes encoding other microRNAs. Accordingly, both miR-378 and miR-499 should regulate other microRNAs because they have the capacity to modulate pathways that direct cardiac gene expression. By comparison, miR-143 should have minimal effects on other cardiac microRNAs. We tested this notion by deep sequencing cardiac microRNAs in miR-143, miR-378, and miR-499 transgenic mice. Principal components analysis of the cardiac microRNA expression signatures (absent the 3 overexpressed microRNAs) shows a pattern of clustering that is strikingly similar to the respective mRNA profiles (compare Figure   Figure 3 . Effects of microRNA (miR)-143, -378, and -499 on cardiac gene expression. A, Volcano plots of cardiac-expressed mRNA regulation (n≈9500) in microRNA overexpressing hearts, compared with littermate controls. Vertical and horizontal bold lines depict threshold levels for ±25% fold-change (horizontal axis) and probability value corresponding to false discovery rate of 0.05 (vertical axis). B, Heat map of normalized expression levels for 1903 microRNA-regulated mRNAs in miR-143 transgenic (TG) and littermate nontransgenic (ntg) mice at 8 weeks of age. C, Heat map depicting unsupervised hierarchical clustering of normalized expression for 1903 microRNA-regulated mRNAs in miR-378 and miR-499 transgenic mice and littermate controls (8 weeks of age for miR-378 transgenic and nontransgenic; 4 weeks of age for miR-499 transgenic and nontransgenic). Distinct regulatory patters are induced by miR-378 and miR-499. For heat maps, each column depicts mRNA expression data from 1 mouse heart; blue designates low expression, and red designates high expression relative to mean level across all samples for each mRNA. Figure 4A ). Unsupervised hierarchical clustering of 300 cardiomiRs according to expression level revealed individual differences in cardiomiR expression profiles invoked by miR-378 and miR-499 ( Figure 4C ; Online Table  II) . The same analysis for miR-143 transgenic mice was indistinguishable from nontransgenic mouse hearts (Online Figure II and Table II ). Using our prespecified thresholds for genome-wide significance in microRNA regulation (25%-fold change at false discovery rate<0.05), miR-378 regulated 31 cardiomiRs (18 up, 31 down), and miR-499 regulated 17 cardiomiRs (11 up, 6 down), with only miRs-34a, 221, and 222 regulated by both ( Figure 4D ). These findings indicate that microRNA-mediated microRNA regulation in hearts is a specific response.
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MicroRNA Processing Is Unaffected by Overexpression, but Passenger Strands Are Rendered More Likely to Have Biological Effects
MicroRNAs are transcribed, processed, and exported from the nucleus as hairpin premicroRNAs, and then further processed into a duplex encoding 2 microRNA strands with different sequences. In most instances, the mature dominant miR (guide strand) is incorporated into RISCs where it targets mRNAs with compatible sequences; the other (passenger) strand is rapidly degraded and consequently is far less abundant. Some microRNA -5p and -3p strands are both inserted into RISCs 30, 31 where they each target their respective complementary mRNAs (reviewed in 32 ). A recent report described retention of both miR-378 strands and, therefore, dual functionality in heart and other tissues. 19 Figure 4. Transcriptome-wide mRNA and microRNA effects of microRNA (miR)-143, -378, and -499. A, Principal components analysis of ≈9500 cardiac-expressed mRNAs (cardiomiRs) in microRNA transgenic (TG) hearts and nontransgenic (ntg) controls. B, Principal components analysis of 300 cardiomiRs in microRNA transgenic (TG) hearts and nontransgenic (ntg) controls. In each data set, the overexpressed microRNA was excluded from analysis. C, Unsupervised hierarchical clustering of expression levels for the 300 cardiomiRs in miR-378 and miR-499 transgenic hearts, compared with littermate controls. D, Exploded heat maps depicting unsupervised clustering according to expression levels of microRNAs regulated at genome-wide significance in miR-378 and miR-499 transgenic hearts, compared with littermate controls. All microRNAs shown represent guide (major) strands of the respective microRNAs, with the exception of miRs-214 and -455, for which both guide and passenger strands were regulated and sufficiently abundant for inclusion within the set of 300 cardiomiRs. C and D, Blue indicates downregulation, whereas red indicates upregulation relative to mean level for each microRNA.
We determined levels of miR-143-3p, -378-3p, and -499-5p (the microRNA guide strands) and passenger strands in normal 4-week-old and 8-week-old hearts from our deep sequencing data. The 5p/3p ratio of each of these cardiomiRs was constant; the dominant guide strands are expressed at levels ≈1 order of magnitude greater than passenger strands ( Figure 5A ). An expanded analysis comprising the 300 most abundant cardiomiRs revealed that the pattern of a highly expressed guide strand and a less abundant passenger strand applies across all the cardiomiRs (Online Figure III) . Remarkably, 85 of the 300 most abundant cardiomiRs are passenger strands, and 12 passenger strands are expressed at levels that place them within the 100 most abundant cardiomiRs ( Figure 1D ), suggesting contextual functionality for at least some cardiomiR passenger strands.
As with normal microRNA transcription, transgenic overexpression of microRNA precursors produces both guide and passenger microRNAs (see Figure 2A) . Thus, transgenic passenger microRNA strands have the potential to be expressed, incorporated within RISCs, and to suppress mRNAs having complementary sequences within their 3ʹ untranslated regions. We tested whether forced microRNA expression perturbs normal elimination of passenger microRNA strands by quantifying miR-143, -378, and -499 passenger and guide strand levels in our transgenic mouse hearts. The respective minor strand microRNAs were preferentially eliminated, maintaining normal ratios of guide and passenger strand even with overexpression ( Figure 5B) . Furthermore, the strong correlation of major-to-minor microRNA ratio for microRNAs regulated by miR-378 or miR-499 ( Figure 5C ) shows that these 2 cardiomiRs do not significantly perturb normal processing or stability of the cardiomiRs they regulate and support a mechanism that involves regulation of transcription.
Nevertheless, the absolute levels of transgenically overexpressed miR-143, -378, and -499 passenger strands move them to the 102nd, 23rd, and 91st most abundant cardiomiRs in their respective transgenic hearts ( Figure 5D ). Although overexpression of the already highly abundant miR-143 and -378 guide strands barely changed their ranking among cardiomiRs, the somewhat less abundant miR-499 guide strand moved from the 51st to the 11th most abundant ( Figure 5D ). The law of mass action dictates that the proportional effect of overexpressed minor microRNAs will be small relative to the respective coexpressed major microRNAs, but transgenic minor microRNAs may nevertheless have measurable effects. We, therefore, identified passenger strand effects according to sequence complementarity and in comparison with biological data (Online Table III ).
Higher Order Consequences of MicroRNAMediated CardiomiR Regulation
We identified 13 miR-378-or miR-499-regulated microRNAs that are encoded within introns of known parent genes ( Figure 6A ). Considering that a transcriptional mechanism of microRNA regulation should exert similar modulatory influences on the regulated cardiomiR and its parent mRNA, we compared the relative change induced by miR-378 and miR-499 on parent gene mRNA with that of the respective daughter cardiomiR. In almost every instance, the parent mRNA and daughter microRNA are coregulated ( Figure 6A ). Because the parent mRNA and daughter microRNA are products of the same transcriptional event, their coregulation supports transcriptional regulation.
To determine the extent to which microRNA-regulated microRNAs contribute to the altered transcriptomic profiles observed in miR-378 and miR-499 transgenic hearts, the FastamiRs algorithm 7 was used at high stringency (see Online Methods) to predict binding between the upregulated microRNAs (including the transgenic microRNAs) and downregulated mRNAs. A total of 468 mRNAs were downregulated in miR-378 transgenic hearts compared with controls (Online Table I ); 290 of these are predicted targets of ≥1 upregulated microRNAs ( Figure 6B , left and center). Seventy-four different mRNAs (16% of all downregulated mRNAs) are targeted by miR-378-3p or miR-378-5p, whereas a further 216 different mRNAs (46%) are targets of the other 3 upregulated microRNAs (Figure 6B , right; Online Table III ). In miR-499 transgenic hearts ( Figure 6C ), 969 mRNAs were downregulated, with 376 of these being predicted targets of upregulated microRNAs. Seventy-six different mRNAs (7.8%) are targets of miR-499-5p or miR-499-3p, whereas 298 different mRNAs (31%) are targeted by the other 12 microRNAs (Figure 6C , right; Online Table III) . Thus, secondary mRNA regulation by microRNA-regulated microRNAs accounts for ≈75% of the microRNA-dependent transcript downregulation in these transgenic models.
Discussion
Here, we describe 2 microRNAs that regulate different sets of other cardiac microRNAs. MicroRNA regulation by other microRNAs has been almost completely ignored when studying mechanisms of microRNA effects. Indeed, the 1 example of microRNA-mediated microRNA regulation within the family of myomiRs seems, since its description in 2007, 8, 9 to have been treated as a unique case rather than as an indication of a broader and more general function of microRNAs. Certainly microRNA-mediated microRNA regulation has not previously been assigned mechanistic importance outside of the special case of the myomiR family. The current studies show that, together with direct mRNA suppression, 1, 32 indirect regulation of mRNA transcription, 7 and regulation of post-translational protein modification, 11 microRNA-mediated microRNA regulation can be a major consequence for some microRNAs. Table III ). Colors represent abundances of microRNAs and mRNAs.
These findings provide further insight into how microRNAs with modest direct effects can provoke dramatic end-organ phenotypes. 6 In designing experiments to assess microRNA-mediated microRNA regulation in the in vivo mouse heart, we chose to study 3 highly expressed and disease-regulated cardiac microRNAs. MiR-143 is one of the most abundant mouse cardiomiRs and is highly expressed in vascular smooth muscle, but virtually nothing is known about its actions in cardiac myocytes. Based on our previous studies examining microRNA expression and regulation in early cardiac hypertrophy, we classified miR-143 as one of the housekeeping microRNAs because it is constitutively expressed at high levels, it regulates essential cellular functions (in other tissues), and was not regulated during early cardiac hypertrophy.
7 Abnormal miR-143 activity has been linked to several cancers via destabilization of hexokinase 2. [25] [26] [27] In our studies, forced expression of miR-143 suppressed its direct target hexokinase 2 by ≈30%, but had virtually no effect on other cardiac mRNAs. Consistent with absence of epitranscriptional activity, cardiomyocyte-specific miR-143 overexpression did not regulate the expression of other cardiomiRs. Of course, miR-143 might have epitranscriptional effects on mRNAs and other microRNAs in other cell types. 28, 33, 34 In contrast to miR-143, miR-378 and miR-499 each regulated hundreds of cardiac-expressed mRNAs and a dozen or so cardiac microRNAs. These 2 stress-modulated cardiomiRs direct biological pathways, broadly orchestrating either metabolic remodeling (miR-378) 19 or hypertrophic remodeling (miR-499).
11 Indeed, we included miR-499 as the most likely candidate to prove our hypothesis that microRNAs directing transcriptional signaling would also regulate expression of other microRNAs. 11 Although both miR-378 and miR-499 were capable of regulating other cardiomiRs, the pattern of their microRNA regulation showed almost no overlap. As illustrated by their respective principal components analyses, the different microRNA expression signatures induced by these 2 microRNAs mirrored their different transcriptional signatures. For example, 2 microRNAs that contribute to the molecular signature of doxorubicin toxicity, miR-34c and miR-208b, 35 are induced by miR-499 but not by miR-378. As previously reported by the Olson laboratory, 9 we detected regulation of miRs-208a and 208b by miR-499, and greatly expanded the number of miR-499-modulated cardiomiRs beyond interactions within this specific microRNA family.
In the absence of evidence for differential processing, and with data showing parallel regulation of microRNA and parent mRNA, our findings reveal microRNA-mediated microRNA regulation to be an epitranscriptional event. 7 Based on these findings, we would anticipate that other microRNAs with modulatory effects on cardiac gene expression, such as miR-1 and miR-22, 36 also have significant effects mediated via their regulation of other cardiac microRNAs. An important consequence of uncovering microRNA-mediated microRNA regulation is the recognition that RISC-enriched transcripts in microRNA-programmed hearts/tissues/cells represent direct mRNA targets of both the primary (transgenic) microRNA and any secondarily increased microRNAs. 7, 11, 13, 37 This does not represent a flaw in the approach of measuring RISC-associated mRNAs to define microRNA targets, but does suggest that concomitant knowledge of microRNA expression signatures is essential to properly interpreting RISC-Seq data. Thus, because the indirect effects of microRNAs include regulation of both mRNA transcription and microRNA transcription, we believe that formal assessment of microRNA-mediated microRNA regulation is essential to understand microRNA effects and phenotypes.
Our observation that some microRNAs regulate other microRNAs adds another layer of complexity to the mechanisms by which these simple molecules direct biological processes. Indeed, some authorities in the field have expressed consternation that the actions of microRNAs are so complex that they can never be fully understood. Although correct from a purely reductionist perspective, we would argue that a linear view of molecular cause and effect ignores the obvious nonlinearity of microRNA signaling. MicroRNAs directly suppress a few mRNAs within target biological pathways. Positive or negative modulation of those pathways induces secondary effects that reverberate throughout the system, amplifying some responses and inhibiting others. miR-499, for example, directly targets phosphatases that post-translationally regulate transcriptional pathways, 11 thereby broadly regulating cardiac gene expression. Indeed, transcriptional pathways seem to be preferentially targeted by cardiomiRs induced during hemodynamic stress. 7 Now, we must include microRNA-mediated microR-NA regulation as another higher order event that contributes to the ultimate effects of a given microRNA ( Figure 7A) . Based on the current results, we can apply this schema to real-world problems of how cardiac genes and microRNAs are epitranscriptionally regulated by miR-378 and miR-499: we bioinformatically identified putative transcription factor binding sites in the promoters of microRNA-regulated microRNAs and parent genes ( Figure 4D ; Online Tables IV and V) using Multi-genome Analysis of Positions and Patterns of Elements of Regulation, 38 and delineated transactivating factors targeted by the respective microRNAs. Thus, miR-99a seems to be indirectly downregulated by miR-378 via its direct targeting of v-maf musculoaponeurotic fibrosarcoma oncogene homolog and retinoic acid receptor-related orphan receptor A. In turn, miR-99a directly targets 31 cardiac-expressed mRNAs (according to TargetScan predictions), accounting for their indirect regulation by miR-378 ( Figure 7B ). Further examples are in Online Table V. Given that the majority of microRNA effects are not the direct result of mRNA suppression, we suggest that terms such as off-target and nonspecific be abandoned in favor of indirect or higher order to reflect our observations that these effects are normal and real, but simply not predicted by available analytics.
The complexity and nonlinearity of microRNA effects does not preclude comprehension of their actions. Rather, like a Mandelbrot set in fractal geometry, where visual complexity results from simple mathematical rules, 39 understanding simply requires a different approach than standard reductionism. Biological systems are sufficiently complex that they cannot be adequately described in terms of individual functioning units. But if the rules that govern the behavior of these units are understood, then the system-wide responses are predictable. It is the complexity of microRNA actions that makes them therapeutically attractive, because parallel effects on multiple targets bypass the usual resiliency of biological systems to interventions that target a single factor. In this context, microRNA-mediated microRNA regulation is one of the consequences of microRNA-directed therapeutics to consider as they move toward clinical applications. Table IV) ; the v-maf musculoaponeurotic fibrosarcoma oncogene homolog and retinoic acid receptor-related orphan receptor A families are predicted to activate transcription of the miR-99a pri-miR (Online Table V) . Procedures for the definition of miR-99a and miR-378a targets are given in Detailed Methods.
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